Human Antibody Domains and Fragments Targeting Neutrophil Elastase as Candidate Therapeutics for Cancer and Inflammation-Related Diseases
Open Access
- 15 October 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (20) , 11136
Abstract
Neutrophil elastase (NE) is a serine protease released during neutrophil maturation. High levels of NE are related to lung tissue damage and poor prognosis in cancer; thus, NE is a potential target for therapeutic immunotherapy for multiple lung diseases and cancers. Here, we isolate and characterize two high-affinity, specific, and noncompetitive anti-NE antibodies Fab 1C10 and VH 1D1.43 from two large phage-displayed human Fab and VH libraries. After fusion with human IgG1 Fc, both of them (VH-Fc 1D1.43 and IgG1 1C10) inhibit NE enzymatic activity with VH-Fc 1D1.43 showing comparable inhibitory effects to that of the small molecule NE inhibitor SPCK and IgG1 1C10 exhibiting even higher (2.6-fold) activity than SPCK. Their epitopes, as mapped by peptide arrays combined with structural modeling, indicate different mechanisms for blocking NE activity. Both VH-Fc and IgG1 antibodies block NE uptake by cancer cells and fibroblast differentiation. VH-Fc 1D1.43 and IgG1 1C10 are promising for the antibody-based immunotherapy of cancer and inflammatory diseases.Keywords
This publication has 44 references indexed in Scilit:
- Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary diseaseBMC Immunology, 2013
- Neutrophil function in inflammation and inflammatory diseasesRheumatology, 2010
- Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growthNature Medicine, 2010
- Structural insight into distinct mechanisms of protease inhibition by antibodiesProceedings of the National Academy of Sciences, 2007
- Optimization of Radioimmunotherapy of Solid Tumors: Biological Impediments and Their ModulationClinical Cancer Research, 2007
- Mice Lacking Neutrophil Elastase Are Resistant to Bleomycin-Induced Pulmonary FibrosisThe American Journal of Pathology, 2007
- Sivelestat, a specific neutrophil elastase inhibitor, suppresses the growth of gastric carcinoma cells by preventing the release of transforming growth factor‐αCancer Science, 2006
- Neutrophil Elastase Predicts Trastuzumab Responsiveness in Metastatic Breast CancerThe Breast Journal, 2006
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung diseaseJournal of Cystic Fibrosis, 2003